BMC Immunology

Papers
(The H4-Index of BMC Immunology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
The diagnostic value and validation of IL-22 combined with sCD40L in tuberculosis pleural effusion58
Innate lymphoid cell dysfunction during long-term suppressive antiretroviral therapy in an African cohort44
Integrated bulk RNA sequencing and mass cytometry analysis reveal the circulating immune landscape in ischemic and hemorrhagic Moyamoya disease30
Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model30
Oxidative stress-related circulating miRNA-27a is a potential biomarker for diagnosis and prognosis in patients with sepsis29
Increased serum adenosine deaminase activity in patients with adult-onset Still's disease29
Incidence of severe adverse events in cancer patients after treatment with immune-checkpoint inhibitors during the COVID- 19 pandemic23
Gentamicin promoted the production of CD4+CD25+ Tregs via the STAT5 signaling pathway in mice sepsis21
Anti-inflammatory protein TNFα-stimulated gene-6 (TSG-6) reduces inflammatory response after brain injury in mice19
A survey of the adaptive immune genes of the polka-dot batfish Ogcocephalus cubifrons19
Natural and induced immune responses in oral cavity and saliva17
The augment of regulatory T cells undermines the efficacy of anti-PD-L1 treatment in cervical cancer17
Sex differences exist in adult heart group 2 innate lymphoid cells16
Histone acetylation risk model predicts prognosis and guides therapy selection in glioblastoma: implications for chemotherapy and anti-CTLA-4 immunotherapy16
Interstitial lung diseases (ILD) in common variable immunodeficiency (CVID) patients: a study from Iran15
0.090914964675903